Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair
Background—Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair
XP Huang, Z Sun, Y Miyagi, HMD Kinkaid… - …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair
XP Huang, Z Sun, Y Miyagi, HMD Kinkaid… - …, 2010 - augusta.elsevierpure.com
Background-: Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
[PDF][PDF] Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
XP Huang, Z Sun, Y Miyagi, HMD Kinkaid, L Zhang… - 2010 - renkelilab.com
Background—Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
[PDF][PDF] Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
XP Huang, Z Sun, Y Miyagi, HMD Kinkaid, L Zhang… - 2010 - scholar.archive.org
Background—Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
XP Huang, Z Sun, Y Miyagi, HMD Kinkaid, L Zhang… - Circulation, 2010 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background—</jats: title>< jats: p> Cardiac cell therapy for older
patients who experience a myocardial infarction may require highly regenerative cells from …
patients who experience a myocardial infarction may require highly regenerative cells from …
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.
XP Huang, Z Sun, Y Miyagi, L Zhang, RD Weisel, RK Li - Circulation, 2010 - europepmc.org
Background Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
[PDF][PDF] Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
XP Huang, Z Sun, Y Miyagi, HMD Kinkaid, L Zhang… - 2010 - Citeseer
Background—Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
[引用][C] Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
XP HUANG, Z SUN, Y MIYAGI… - … (New York, NY), 2010 - pascal-francis.inist.fr
Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits
Their Long-Term Benefits for Myocardial Repair CNRS Inist Pascal-Francis CNRS Pascal …
Their Long-Term Benefits for Myocardial Repair CNRS Inist Pascal-Francis CNRS Pascal …
Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
XP Huang, Z Sun, Y Miyagi, HMD Kinkaid, L Zhang… - 2010 - Am Heart Assoc
Background—Cardiac cell therapy for older patients who experience a myocardial infarction
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …
may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow …